Chemotherapy with si-RNA and Anti-Cancer Drugs

Kamaljeet Kaur; Goutam Rath; Saket Chandra; Ranjit Singh; Amit Kumar Goyal

doi:10.2174/1567201814666170518141440

Chemotherapy with si-RNA and Anti-Cancer Drugs

Kamaljeet Kaur, Goutam Rath, Saket Chandra, Ranjit Singh, Amit Kumar Goyal

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

BACKGROUND: To treat cancer, chemotherapy is a key therapeutic approach which is associated with several limitations. This chemotherapeutical agent exhibits multi drug resistance coupled with undesirable side effects. This multidrug resistance is exhibited by tumor cell due to actuation of drug out flow mechanism, programmed cell death and protection mechanisms etc. One of the therapeutic approaches to cure cancer is RNA interference (RNAi). Small interfering RNA (si-RNA) is considered as a major therapeutic tool used to control expression of a particular gene. It is a well known fact that intake of more drugs can lead to cancer chemo resistance, thus siRNA based therapeutic approach is under scrutiny to cure cancer.

Original language	English (US)
Pages (from-to)	300-311
Number of pages	12
Journal	Current Drug Delivery
Volume	15
Issue number	3
DOIs	https://doi.org/10.2174/1567201814666170518141440
State	Published - Jan 1 2018
Externally published	Yes

Bibliographical note

Generated from Scopus record by KAUST IRTS on 2023-10-12

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2174/1567201814666170518141440

Cite this

@article{671867a9482d45b9becbf05394ff225f,

title = "Chemotherapy with si-RNA and Anti-Cancer Drugs",

abstract = "BACKGROUND: To treat cancer, chemotherapy is a key therapeutic approach which is associated with several limitations. This chemotherapeutical agent exhibits multi drug resistance coupled with undesirable side effects. This multidrug resistance is exhibited by tumor cell due to actuation of drug out flow mechanism, programmed cell death and protection mechanisms etc. One of the therapeutic approaches to cure cancer is RNA interference (RNAi). Small interfering RNA (si-RNA) is considered as a major therapeutic tool used to control expression of a particular gene. It is a well known fact that intake of more drugs can lead to cancer chemo resistance, thus siRNA based therapeutic approach is under scrutiny to cure cancer.",

author = "Kamaljeet Kaur and Goutam Rath and Saket Chandra and Ranjit Singh and Goyal, {Amit Kumar}",

note = "Generated from Scopus record by KAUST IRTS on 2023-10-12",

year = "2018",

month = jan,

day = "1",

doi = "10.2174/1567201814666170518141440",

language = "English (US)",

volume = "15",

pages = "300--311",

journal = "Current Drug Delivery",

issn = "1875-5704",

publisher = "Bentham Science Publishers B.V.",

number = "3",

}

TY - JOUR

T1 - Chemotherapy with si-RNA and Anti-Cancer Drugs

AU - Kaur, Kamaljeet

AU - Rath, Goutam

AU - Chandra, Saket

AU - Singh, Ranjit

AU - Goyal, Amit Kumar

N1 - Generated from Scopus record by KAUST IRTS on 2023-10-12

PY - 2018/1/1

Y1 - 2018/1/1

N2 - BACKGROUND: To treat cancer, chemotherapy is a key therapeutic approach which is associated with several limitations. This chemotherapeutical agent exhibits multi drug resistance coupled with undesirable side effects. This multidrug resistance is exhibited by tumor cell due to actuation of drug out flow mechanism, programmed cell death and protection mechanisms etc. One of the therapeutic approaches to cure cancer is RNA interference (RNAi). Small interfering RNA (si-RNA) is considered as a major therapeutic tool used to control expression of a particular gene. It is a well known fact that intake of more drugs can lead to cancer chemo resistance, thus siRNA based therapeutic approach is under scrutiny to cure cancer.

AB - BACKGROUND: To treat cancer, chemotherapy is a key therapeutic approach which is associated with several limitations. This chemotherapeutical agent exhibits multi drug resistance coupled with undesirable side effects. This multidrug resistance is exhibited by tumor cell due to actuation of drug out flow mechanism, programmed cell death and protection mechanisms etc. One of the therapeutic approaches to cure cancer is RNA interference (RNAi). Small interfering RNA (si-RNA) is considered as a major therapeutic tool used to control expression of a particular gene. It is a well known fact that intake of more drugs can lead to cancer chemo resistance, thus siRNA based therapeutic approach is under scrutiny to cure cancer.

UR - http://www.eurekaselect.com/152561/article

UR - http://www.scopus.com/inward/record.url?scp=85042379887&partnerID=8YFLogxK

U2 - 10.2174/1567201814666170518141440

DO - 10.2174/1567201814666170518141440

M3 - Article

SN - 1875-5704

VL - 15

SP - 300

EP - 311

JO - Current Drug Delivery

JF - Current Drug Delivery

IS - 3

ER -

Chemotherapy with si-RNA and Anti-Cancer Drugs

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this